相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
Tianshu Xiao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z. Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
Kirill Gorshkov et al.
ACS INFECTIOUS DISEASES (2021)
Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics
Hu Zhu et al.
SCIENTIFIC REPORTS (2021)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Franck Touret et al.
SCIENTIFIC REPORTS (2020)
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
Stuart Weston et al.
JOURNAL OF VIROLOGY (2020)
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
Wei Zhu et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
Catherine Z. Chen et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
Naidi Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Bigger is better in virtual drug screens
David E. Gloriam
NATURE (2019)
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Jean K. Millet et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
Shu Yang et al.
CELL DISCOVERY (2018)
Prophylactic Efficacy of Quercetin 3-β-O-D-Glucoside against Ebola Virus Infection
Xiangguo Qiu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
Miao Xu et al.
NATURE MEDICINE (2016)
A cell-based quantitative high-throughput image screening identified novel autophagy modulators
Yuan Li et al.
PHARMACOLOGICAL RESEARCH (2016)
Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization
Ruili Huang et al.
NATURE COMMUNICATIONS (2016)
New Publicly Available Chemical Query Language, CSRML, To Support Chemotype Representations for Application to Data Mining and Modeling
Chihae Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Using Information from Historical High-Throughput Screens to Predict Active Compounds
Sereina Riniker et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A. Mathews Griner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
Jennifer Kouznetsova et al.
EMERGING MICROBES & INFECTIONS (2014)
Virtual Screening Strategies in Drug Discovery: A Critical Review
A. Lavecchia et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Rethinking Molecular Similarity: Comparing Compounds on the Basis of Biological Activity
Faula M. Petrone et al.
ACS CHEMICAL BIOLOGY (2012)
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Ruili Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The Pilot Phase of the NIH Chemical Genomics Center
Craig J. Thomas et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Weighted Feature Significance: A Simple, Interpretable Model of Compound Toxicity Based on the Statistical Enrichment of Structural Features
Ruili Huang et al.
TOXICOLOGICAL SCIENCES (2009)
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication
Renate Konig et al.
CELL (2008)
A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker
Ming-Hsuang Cho et al.
TOXICOLOGY IN VITRO (2008)
Virtual screening strategies in drug discovery
Campbell McInnes
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library
William E. Severson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Self-organizing neural projections
Teuvo Kohonen
NEURAL NETWORKS (2006)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
分享论文
